STOCK TITAN
  1. Home
  2. Sec-filings
  3. OGEN
  4. [EFFECT] ORAGENICS INC SEC Filing

[EFFECT] ORAGENICS INC SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: March 20, 2026 4:00 P.M.
Form: S-3
CIK: 0001174940
Company Name: ORAGENICS INC
File Number: 333-292880

Source: View Original Filing on SEC EDGAR

Oragenics

NYSE:OGEN

View OGEN Stock Overview →

OGEN Rankings

#6912 Ranked by Market Cap
N/A Ranked by Dividends

OGEN Latest News

Mar 25, 2026
Oragenics, Inc. Receives Audit Opinion with Going Concern Explanation
Mar 17, 2026
ORAGENICS FILES ANNUAL REPORT ON FORM 10-K
Mar 12, 2026
ORAGENICS INITIATES PHASE IIA CLINICAL TRIAL SITE ACTIVATION
Mar 11, 2026
ORAGENICS EXPLORES EXPANSION OF CNS PLATFORM PURSUING ACQUISTION OF ASSETS IN BRAIN HEALTH, RECOVERY, AND NEUROPROTECTION
Mar 10, 2026
Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia

OGEN Latest SEC Filings

Mar 19, 2026
[S-3/A] ORAGENICS INC Amended Shelf Registration Statement
Mar 16, 2026
[10-K] ORAGENICS INC Files Annual Report
Mar 11, 2026
[8-K] ORAGENICS INC Reports Material Event
Jan 22, 2026
[S-3] ORAGENICS INC Shelf Registration Statement
Jan 22, 2026
[8-K] ORAGENICS INC Reports Material Event

OGEN Stock Data

2.51M
4.24M
Biotechnology
Pharmaceutical Preparations
Link
United States
LAKEWOOD RANCH